iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionTraynor Capital Management, Inc.
Latest Disclosed Ownership13,287 shares
Latest Disclosed Value $ 2,150,583
Traynor Capital Management, Inc. reports 14.22% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Traynor Capital Management, Inc. filed a 13F-HR form disclosing ownership of 13,287 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,150,583 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 11,633 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 14.22% during the quarter. The current value of the position is $1,741,261 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,287 1,654 14.22 2,151 9.53 0.1261
2026-01-12 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,633 355 3.15 1,963 20.58 0.1048
2025-11-03 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,278 -4,597 -28.96 1,628 -19.64 0.0929
2025-08-07 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,875 -5,977 -27.35 2,026 -27.49 0.1437
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 21,852 -1,107 -4.82 2,795 -7.94 0.2355
2025-01-17 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 22,959 -2,045 -8.18 3,035 -16.62 0.2028
2024-10-25 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 25,004 2,525 11.23 3,641 17.99 0.2182
2024-07-24 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 22,479 972 4.52 3,085 4.54 0.2312
2024-04-12 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 21,507 2,294 11.94 2,951 13.07 0.2557
2024-01-18 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 19,213 -1,009 -4.99 2,610 5.58 0.2681
2023-10-16 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 20,222 1,102 5.76 2,473 1.85 0.3099
2023-07-28 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 19,120 492 2.64 2,428 0.91 0.2979
2023-04-21 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,628 2 0.01 2,406 -1.64 0.3474
2023-01-27 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,626 1,396 8.10 2,445 21.34 0.3448
2022-11-15 2022-09-30 13F/A-3 ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 17,230 -1,473 -7.88 2,015 -8.41 0.3598
2022-10-20 2022-09-30 13F ISHARES BIOTECHNOLOGY ETF ISHARES BIOTECH 464287556 11,568 -7,135 1,352 0.5108
2022-07-28 2022-06-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 18,703 -13,361 -41.67 2,200 -47.33 0.3814
2022-04-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH NASDAQ BIOTECH 464287556 32,064 -5,534 -14.72 4,177 -27.20 0.5417
2022-02-01 2021-12-31 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 37,598 -550 -1.44 5,738 -6.96 0.6788
2021-10-25 2021-09-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 38,148 -287 -0.75 6,167 -2.59 0.8447
2021-07-21 2021-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 38,435 2,132 5.87 6,331 15.85 0.8847
2021-07-21 2021-06-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 38,435 2,132 6,331 0.8847
2021-05-04 2021-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 36,303 2,443 7.22 5,465 6.55 0.9017
2021-01-14 2020-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 33,860 -2,353 -6.50 5,129 3.78 0.9098
2020-10-26 2020-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 36,213 1,499 4.32 4,942 4.15 1.1310
2020-08-10 2020-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 34,714 16,438 89.94 4,745 140.99 1.1427
2020-04-29 2020-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 18,276 4,939 37.03 1,969 22.53 0.6992
2020-01-24 2019-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 13,337 -581 -4.17 1,607 16.11 0.4290
2019-11-01 2019-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 13,918 -623 -4.28 1,384 -13.23 0.4331
2019-07-26 2019-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 14,541 29 0.20 1,595 -1.66 0.5186
2019-04-12 2019-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 14,512 544 3.89 1,622 20.51 0.5430
2019-01-24 2018-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 13,968 -258 -1.81 1,346 -22.38 0.5609
2018-10-24 2018-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 14,226 571 4.18 1,734 14.83 0.5632
2018-08-03 2018-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 13,655 1,195 9.59 1,510 13.53 0.5512
2018-05-01 2018-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 12,460 929 8.06 1,330 8.04 0.5397
2018-01-31 2017-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 11,531 8,186 244.72 1,231 11.30 0.5255
2017-10-27 2017-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,345 -363 -9.79 1,106 -6.59 0.5260
2017-08-02 2017-06-30 13F ISHARES TR NASDAQ BIOTECH NASDQ BIOTEC ETF 464287556 3,708 285 8.33 1,184 16.08 0.5845
2017-05-11 2017-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 3,423 301 9.64 1,020 20.85 0.5698
2017-02-07 2016-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 3,122 214 7.36 844 8.62 0.5595
2016-11-10 2016-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,908 406 16.23 777 19.54 0.5492
2016-07-27 2016-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,502 -293 -10.48 650 -10.84 0.5084
2016-04-18 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,795 -371 -11.72 729 -31.93 0.5810
2016-02-16 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 3,166 475 17.65 1,071 31.25 0.7703
2016-02-23 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,691 153 6.03 816 -12.82 0.7049
2016-02-23 2015-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,538 76 3.09 936 10.77 0.7815
2016-02-23 2015-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,462 182 7.98 845 22.29 0.8108
2016-02-23 2014-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDQ BIOTEC ETF 464287556 2,280 2,280 691 0.8036
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.